Loading...
Turning Point Brands Q1 2025 Earnings Report
Turning Point Brands announced its first quarter 2025 financial results, reporting significant increases in net sales, net income, and adjusted EBITDA.
Key Takeaways
Turning Point Brands reported strong first quarter 2025 results with net sales increasing 28.1% year-over-year to $106.4 million, driven by substantial growth in Modern Oral sales. Net income rose by 19.8% to $14.4 million, and adjusted EBITDA increased by 12.0% to $27.7 million.
Net Sales for Q1 2025 increased 28.1% year-over-year to $106.4 million.
Modern Oral Net Sales for Q1 2025 reached $22.3 million, nearly 10-times higher than the prior year.
Adjusted EBITDA for Q1 2025 was $27.7 million, up 12.0% over the prior year.
The company reaffirmed its full-year 2025 Adjusted EBITDA guidance and increased its full-year consolidated nicotine pouch sales guidance.
Revenue by Segment
Forward Guidance
Turning Point Brands is increasing its projected Modern Oral sales guidance for the full year 2025 and maintaining its Adjusted EBITDA guidance.
Positive Outlook
- Increasing full-year consolidated nicotine pouch sales guidance to a range of $80.0 – 95.0 million, from $60.0 – 80.0 million.
- Maintaining previous expectation for full-year 2025 Adjusted EBITDA of $108.0 – 113.0 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...